Ivana V. Yang

Ivana V. Yang

Auto-generated profile, based on publicly available information

Ivana V. Yang

Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2013 in Thorax
Verified
Journal Article
Open access
PDF file
IYIvana V Yang
Ivana V Yang
CCChristopher D Coldren
Christopher D Coldren
SLSonia M Leach
Sonia M Leach
MSMax A Seibold
Max A Seibold
EMElissa Murphy
Elissa Murphy
DSDavid A Schwartz
David A Schwartz
Background Idiopathic pulmonary fibrosis (IPF) is an untreatable lung disease with a median survival of only 3–5 years that is diagnosed using a combination of clinical, radiographic and pathologic criteria. Histologically, IPF is characterised by usual interstitial pneumonia (UIP), a fibrosing interstitial pneumonia with a pattern of heterogeneous, subpleural regions of fibrotic and remodelled lung. We hypothesised that gene expression profiles of lung tissue may identify molecular subtypes of disease that could classify subtypes of IPF/UIP that have clinical implications. Methods and findings We collected transcriptional profiles on lung tissue from 119 patients with IPF/UIP and 50 non-diseased controls. Differential expression of individual transcripts was identified using an analysis of covariance (ANCOVA) model incorporating the clinical diagnosis of each patient as well as age, gender and smoking status. Validation was performed in an independent cohort of 111 IPF/UIP and 39 non-diseased controls. Our analysis identified two subtypes of IPF/UIP based on a strong molecular signature associated with expression of genes previously associated with fibrosis (matrix metalloproteinases, osteopontin, keratins), cilium genes and genes with unknown function. We demonstrate that elevated expression of cilium genes is associated with more extensive microscopic honeycombing and higher expression of both the airway mucin gene MUC5B and the metalloproteinase MMP7, a gene recently implicated in attenuating ciliated cell differentiation during wound repair. Conclusions Expression of cilium genes appears to identify two unique molecular phenotypes of IPF/UIP. The different molecular profiles may be relevant to therapeutic responsiveness in patients with IPF/UIP.

1 December 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
IYIvana V. Yang
Ivana V. Yang
BPBrent S. Pedersen
Brent S. Pedersen
EREinat Rabinovich
Einat Rabinovich
CHCorinne E. Hennessy
Corinne E. Hennessy
EDElizabeth J. Davidson
Elizabeth J. Davidson
DSDavid A. Schwartz
David A. Schwartz
Rationale: Idiopathic pulmonary fibrosis (IPF) is an untreatable and often fatal lung disease that is increasing in prevalence and is caused by complex interactions between genetic and environmental factors. Epigenetic mechanisms control gene expression and are likely to regulate the IPF transcriptome. Objectives: To identify methylation marks that modify gene expression in IPF lung. Methods: We assessed DNA methylation (comprehensive high-throughput arrays for relative methylation arrays [CHARM]) and gene expression (Agilent gene expression arrays) in 94 patients with IPF and 67 control subjects, and performed integrative genomic analyses to define methylation–gene expression relationships in IPF lung. We validated methylation changes by a targeted analysis (Epityper), and performed functional validation of one of the genes identified by our analysis. Measurements and Main Results: We identified 2,130 differentially methylated regions (DMRs; <5% false discovery rate), of which 738 are associated with significant changes in gene expression and enriched for expected inverse relationship between methylation and expression (P < 2.2 × 10−16). We validated 13/15 DMRs by targeted analysis of methylation. Methylation–expression quantitative trait loci (methyl-eQTL) identified methylation marks that control cis and trans gene expression, with an enrichment for cis relationships (P < 2.2 × 10−16). We found five trans methyl-eQTLs where a methylation change at a single DMR is associated with transcriptional changes in a substantial number of genes; four of these DMRs are near transcription factors (castor zinc finger 1 [CASZ1], FOXC1, MXD4, and ZDHHC4). We studied the in vitro effects of change in CASZ1 expression and validated its role in regulation of target genes in the methyl-eQTL. Conclusions: These results suggest that DNA methylation may be involved in the pathogenesis of IPF.

1 May 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IYIvana V. Yang
Ivana V. Yang
BPBrent S. Pedersen
Brent S. Pedersen
ALAndrew H. Liu
Andrew H. Liu
GOGeorge T. O'Connor
George T. O'Connor
DPDinesh Pillai
Dinesh Pillai
DSDavid Albert Schwartz
David Albert Schwartz

1 July 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IYIvana V. Yang
Ivana V. Yang
CLCatherine A. Lozupone
Catherine A. Lozupone
DSDavid A. Schwartz
David A. Schwartz

1 November 2015 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
IYIvana V. Yang
Ivana V. Yang
TFTasha E. Fingerlin
Tasha E. Fingerlin
CEChristopher M. Evans
Christopher M. Evans
MSMarvin I. Schwarz
Marvin I. Schwarz
DSDavid A. Schwartz
David A. Schwartz
Idiopathic pulmonary fibrosis (IPF), a fatal disease that is a result of complex interactions between genetics and the environment, has limited treatment options. We have identified the MUC5B promoter polymorphism and other common genetic variants that in aggregate explain roughly one-third of disease risk. The MUC5B promoter polymorphism is the strongest and the most replicated genetic risk factor for IPF, appears to be protective and predictive in this disease, and is likely involved in disease pathogenesis through an increase in MUC5B expression in terminal bronchi and honeycombed cysts. Expression of MUC5B is also highly correlated with expression of cilium genes in IPF lung. Our work suggests that mucociliary dysfunction in the distal airway may play a role in the development of progressive fibroproliferative lung disease. In addition, our work has important implications for secondary prevention, early detection, and future early and personalized treatment based on genetic profiles.

1 September 2015 in Current Opinion in Pulmonary Medicine
Verified
Journal Article
Closed access
BHBritney A. Helling
Britney A. Helling
IYIvana V. Yang
Ivana V. Yang
Purpose of review Idiopathic pulmonary fibrosis (IPF) is a fatal disease with limited treatment options and extensive gene expression changes identified in the lung parenchyma. Multiple lines of evidence suggest that epigenetic factors contribute to dysregulation of gene expression in IPF lung. Most importantly, risk factors that predispose to IPF – age, sex, cigarette smoke, and genetic variants – all influence epigenetic marks. This review summarizes recent findings of association of DNA methylation and histone modifications with the presence of disease and fibroproliferation. Recent findings In addition to targeted studies focused on specific gene loci, genome-wide profiles of DNA methylation demonstrate widespread DNA methylation changes in IPF lung tissue and a substantial effect of these methylation changes on gene expression. Genetic loci that have been recently associated with IPF also contain differentially methylated regions, suggesting that genetic and epigenetic factors act in concert to dysregulate gene expression in IPF lung. Summary Although we are in very early stages of understanding the role of epigenetics in IPF, the potential for the use of epigenetic marks as biomarkers and therapeutic targets is high and discoveries made in this field will likely bring us closer to better prognosticating and treating this fatal disease.